Performance of the recommended ESC/EASD cardiovascular risk stratification model in comparison to SCORE and NT-proBNP as a single biomarker for risk prediction in type 2 diabetes mellitus

N-terminal Pro B-type Natriuretic Peptide and High-sensitivity Cardiac Troponin as Markers for Heart Failure and Cardiovascular Disease Risks According to Glucose Status (from the Multi-Ethnic Study of Atherosclerosis [MESA])

(2020) Khoa Nguyen et al.   AMERICAN JOURNAL OF CARDIOLOGY

Clinical and Biomarker Predictors of Expanded Heart Failure Outcomes in Patients With Type 2 Diabetes Mellitus After a Recent Acute Coronary Syndrome: Insights From the EXAMINE Trial

(2020) Abhinav Sharma et al.   Journal of the American Heart Association

Biomarker-defined pathways for incident type 2 diabetes and coronary heart disease—a comparison in the MONICA/KORA study

(2020) Cornelia Huth et al.   Cardiovascular Diabetology

NT‐proBNP by Itself Predicts Death and Cardiovascular Events in High‐Risk Patients With Type 2 Diabetes Mellitus

(2020) Marcus V. B. Malachias et al.   Journal of the American Heart Association

2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD

(2019) Francesco Cosentino et al.   EUROPEAN HEART JOURNAL

2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk

(2019) François Mach et al.   EUROPEAN HEART JOURNAL

High-sensitivity troponin I and B-type natriuretic peptide biomarkers for prediction of cardiovascular events in patients with coronary artery disease with and without diabetes mellitus

(2019) Yuen-Kwun Wong et al.   Cardiovascular Diabetology

Prevalence of cardiovascular disease in type 2 diabetes: a systematic literature review of scientific evidence from across the world in 2007–2017

(2018) Thomas R. Einarson et al.   Cardiovascular Diabetology

2018 ESC/ESH Guidelines for the management of arterial hypertension

(2018) Bryan Williams et al.   EUROPEAN HEART JOURNAL

The prognostic value of troponin T and N‐terminal pro B‐type natriuretic peptide, alone and in combination, in heart failure patients with and without diabetes

(2018) Rasmus Rørth et al.   EUROPEAN JOURNAL OF HEART FAILURE

Serotonin improves glucose metabolism by Serotonylation of the small GTPase Rab4 in L6 skeletal muscle cells

(2017) Ramona Al-Zoairy et al.   Diabetology & Metabolic Syndrome

Role of B‐Type Natriuretic Peptide and N‐Terminal Prohormone BNP as Predictors of Cardiovascular Morbidity and Mortality in Patients With a Recent Coronary Event and Type 2 Diabetes Mellitus

(2017) Emil Wolsk et al.   Journal of the American Heart Association

Impact of Body Mass Index on the Accuracy of N-Terminal Pro-Brain Natriuretic Peptide and Brain Natriuretic Peptide for Predicting Outcomes in Patients With Chronic Heart Failure and Reduced Ejection Fraction

(2016) Wilson Nadruz et al.   CIRCULATION

Natriuretic Peptide and High-Sensitivity Troponin for Cardiovascular Risk Prediction in Diabetes: The Atherosclerosis Risk in Communities (ARIC) Study

(2016) Mauro Gori et al.   DIABETES CARE

2016 European Guidelines on cardiovascular disease prevention in clinical practice

(2016) Massimo F. Piepoli et al.   EUROPEAN HEART JOURNAL

Prognostic Implications of Biomarker Assessments in Patients With Type 2 Diabetes at High Cardiovascular Risk

(2016) Benjamin M. Scirica et al.   JAMA Cardiology

Additive prognostic value of plasma N-terminal pro-brain natriuretic peptide and coronary artery calcification for cardiovascular events and mortality in asymptomatic patients with type 2 diabetes

(2015) Bernt Johan von Scholten et al.   Cardiovascular Diabetology

Prognostic role of N-terminal pro-brain natriuretic peptide in asymptomatic hypertensive and diabetic patients in primary care: impact of age and gender

(2015) Piercarlo Ballo et al.   Clinical Research in Cardiology

Protein biomarkers for the prediction of cardiovascular disease in type 2 diabetes

(2015) Helen C. Looker et al.   DIABETOLOGIA

Diabetes and Prior Coronary Heart Disease are Not Necessarily Risk Equivalent for Future Coronary Heart Disease Events

(2015) Jamal S. Rana et al.   JOURNAL OF GENERAL INTERNAL MEDICINE

N-terminal pro-brain natriuretic peptide and risk of cardiovascular events in older patients with type 2 diabetes: the Edinburgh Type 2 Diabetes Study

(2014) Anna H. Price et al.   DIABETOLOGIA

The Relative and Combined Ability of High-Sensitivity Cardiac Troponin T and N-Terminal Pro-B-Type Natriuretic Peptide to Predict Cardiovascular Events and Death in Patients With Type 2 Diabetes

(2013) Graham S. Hillis et al.   DIABETES CARE

Natriuretic Peptide–Based Screening and Collaborative Care for Heart Failure

(2013) Mark Ledwidge et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

PONTIAC (NT-proBNP Selected PreventiOn of cardiac eveNts in a populaTion of dIabetic patients without A history of Cardiac disease)

(2013) Martin Huelsmann et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Cost-Effectiveness of N-Terminal Pro-B-Type Natriuretic-Guided Therapy in Elderly Heart Failure Patients

(2013) Sandra Sanders-van Wijk et al.   JACC-Heart Failure

Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies

(2010) The Emerging Risk Factors Collaboration   LANCET

Cardiovascular risk assessment scores for people with diabetes: a systematic review

(2009) P. Chamnan et al.   DIABETOLOGIA

The Role of N-terminal PRO-Brain Natriuretic Peptide and Echocardiography for Screening Asymptomatic Left Ventricular Dysfunction in a Population at High Risk for Heart Failure. The PROBE-HF Study

(2009) Irene Betti et al.   JOURNAL OF CARDIAC FAILURE

Is diabetes a coronary risk equivalent? Systematic review and meta-analysis

(2008) U. Bulugahapitiya et al.   DIABETIC MEDICINE

NT-proBNP has a high negative predictive value to rule-out short-term cardiovascular events in patients with diabetes mellitus

(2008) M. Huelsmann et al.   EUROPEAN HEART JOURNAL